Cognitively healthy elderly people who experience atrophy in the amygdala and hippocampus are more likely to develop dementia, according to a study in the January Archives of General Psychiatry.
Cognitively healthy elderly people who experience atrophy in the amygdala and hippocampus are more likely to develop dementia, according to a study in the January Archives of General Psychiatry.
Dr. Tom den Heijer and colleagues of the Erasmus Medical Center in Rotterdam used MRI to assess the brain volumes of 511 dementia-free elderly subjects in the Rotterdam Study, a large population-based cohort study that began in 1990.
Over the six-year follow-up period, 35 participants developed dementia, and 26 of those were diagnosed with Alzheimer's disease. Volume reductions between 5% and 17% were strongly associated with the development of dementia, according to the study. In participants with mild to moderate AD, volume reduction rates were between 25% and 40%, suggesting that atrophy rates accelerate in patients with AD.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.